Pharmacokinetic characteristics for CC-223 and principal metabolite (M1) in patients with NET initially treated with 30 mg or 45 mg CC-223.
收藏Figshare2019-09-17 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/Pharmacokinetic_characteristics_for_CC-223_and_principal_metabolite_M1_in_patients_with_NET_initially_treated_with_30_mg_or_45_mg_CC-223_/9864854
下载链接
链接失效反馈官方服务：
资源简介：
Pharmacokinetic characteristics for CC-223 and principal metabolite (M1) in patients with NET initially treated with 30 mg or 45 mg CC-223.
创建时间：
2019-09-17
